Normal view MARC view ISBD view

Calling a condition H(elp). [electronic resource]

By:

Greenhouse, Pamela K

Contributor(s):

Producer: 20061128Description: 63-6 p. digitalISSN:

0002-936X

Subject(s):

Online resources:

Available from publisher's website

In: The American journal of nursing vol. 106

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1 N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease.
by Jarai, Rudolf
2 Circulating B-type natriuretic peptides in patients with acute coronary syndromes. Pathophysiological, prognostical and therapeutical considerations.
by Jarai, Rudolf
3 Platelet function variability and non-genetic causes.
by Tentzeris, Ioannis
4 Midregional pro-A-type natriuretic peptide as part of a dual biomarker strategy for the early rule out of non-ST segment elevation acute coronary syndrome - The WilCop study.
by Tajsic, Milos
5 Usefulness of pre-operative copeptin concentrations to predict post-operative outcome after major vascular surgery.
by Jarai, Rudolf
6 Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
by Jarai, Rudolf
7 Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure.
by Tentzeris, Ioannis
8 Long-term outcome after drug-eluting stent implantation in comparison with bare metal stents: a single centre experience.
by Tentzeris, Ioannis
9 Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
by Jarai, Rudolf
10 Human cardiac fibroblasts express B-type natriuretic peptide: fluvastatin ameliorates its up-regulation by interleukin-1alpha, tumour necrosis factor-alpha and transforming growth factor-beta.
by Jarai, Rudolf
11 The role of ST-segment elevation in lead aVR in the risk assessment of patients with acute pulmonary embolism.
by Janata, Karin
12 Levels of von Willebrand factor and ADAMTS13 determine clinical outcome after cardioversion for atrial fibrillation.
by Freynhofer, Matthias K
13 Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
by Tentzeris, Ioannis
14 Predictive value of plasma Nt-proBNP and body mass index for recurrence of atrial fibrillation after cardioversion.
by Freynhofer, Matthias K
15 Prediction of clinical outcome in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) using the TIMI risk score extended by N-terminal pro-brain natriuretic peptide levels.
by Jarai, Rudolf
16 Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease.
by Farhan, Serdar
17 Contrast induced acute kidney injury in acute coronary syndrome patients: A single centre experience.
by Farhan, Serdar
18 Sex-related differences in baseline characteristics, management and outcome in patients with acute coronary syndrome without ST-segment elevation.
by Vogel, Birgit
19 Fasting glucose, NT-proBNP, treatment with eptifibatide, and outcomes in non-ST-segment elevation acute coronary syndromes: An analysis from EARLY ACS.
by Farhan, Serdar
20 Variability of on-treatment platelet reactivity in patients on clopidogrel.
by Freynhofer, Matthias K